View in EDS PDF Full Text

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
Authors: Dowlati A; Developmental Therapeutics Program, CASE Comprehensive Cancer Center and the Division of Hematology/Oncology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio, USA. afshin.dowlati@case.edu, Chapman R, Subbiah S, Fu P, Ness A, Cortas T, Patrick L, Reynolds S, Xu N, Levitan N, Ivy P, Remick SC
Source: Investigational new drugs [Invest New Drugs] 2005 Dec; Vol. 23 (6), pp. 563-7.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Print ISSN: 0167-6997 (Print) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 16034518
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dowlati+A%22">Dowlati A</searchLink>; Developmental Therapeutics Program, CASE Comprehensive Cancer Center and the Division of Hematology/Oncology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio, USA. afshin.dowlati@case.edu<br /><searchLink fieldCode="AU" term="%22Chapman+R%22">Chapman R</searchLink><br /><searchLink fieldCode="AU" term="%22Subbiah+S%22">Subbiah S</searchLink><br /><searchLink fieldCode="AU" term="%22Fu+P%22">Fu P</searchLink><br /><searchLink fieldCode="AU" term="%22Ness+A%22">Ness A</searchLink><br /><searchLink fieldCode="AU" term="%22Cortas+T%22">Cortas T</searchLink><br /><searchLink fieldCode="AU" term="%22Patrick+L%22">Patrick L</searchLink><br /><searchLink fieldCode="AU" term="%22Reynolds+S%22">Reynolds S</searchLink><br /><searchLink fieldCode="AU" term="%22Xu+N%22">Xu N</searchLink><br /><searchLink fieldCode="AU" term="%22Levitan+N%22">Levitan N</searchLink><br /><searchLink fieldCode="AU" term="%22Ivy+P%22">Ivy P</searchLink><br /><searchLink fieldCode="AU" term="%22Remick+SC%22">Remick SC</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309330%22">Investigational new drugs</searchLink> [Invest New Drugs] 2005 Dec; Vol. 23 (6), pp. 563-7.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309330 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0167-6997 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676997%22">01676997 </searchLink><i>NLM ISO Abbreviation: </i>Invest New Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=16034518
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10637-005-0754-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 563
    Titles:
      – TitleFull: Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dowlati A
      – PersonEntity:
          Name:
            NameFull: Chapman R
      – PersonEntity:
          Name:
            NameFull: Subbiah S
      – PersonEntity:
          Name:
            NameFull: Fu P
      – PersonEntity:
          Name:
            NameFull: Ness A
      – PersonEntity:
          Name:
            NameFull: Cortas T
      – PersonEntity:
          Name:
            NameFull: Patrick L
      – PersonEntity:
          Name:
            NameFull: Reynolds S
      – PersonEntity:
          Name:
            NameFull: Xu N
      – PersonEntity:
          Name:
            NameFull: Levitan N
      – PersonEntity:
          Name:
            NameFull: Ivy P
      – PersonEntity:
          Name:
            NameFull: Remick SC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2005 Dec
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 0167-6997
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Investigational new drugs
              Type: main
ResultId 1